VETOQUINOL INH. EO 250
Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products for cattle, pigs, dogs, and cats in Europe, the Americas, and the Asia Pacific region. It offers products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; antibiotics; reproduction; behavior management; internal … Read more
Market Cap & Net Worth: VETOQUINOL INH. EO 250 (8JM)
VETOQUINOL INH. EO 250 (F:8JM) has a market capitalization of $947.14 Million (€922.71 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #12741 globally and #1349 in its home market, demonstrating a 0.26% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying VETOQUINOL INH. EO 250's stock price €78.20 by its total outstanding shares 11799419 (11.80 Million).
VETOQUINOL INH. EO 250 Market Cap History: 2021 to 2026
VETOQUINOL INH. EO 250's market capitalization history from 2021 to 2026. Data shows change from $1.56 Billion to $947.14 Million (-4.44% CAGR).
VETOQUINOL INH. EO 250 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how VETOQUINOL INH. EO 250's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 8JM by Market Capitalization
Companies near VETOQUINOL INH. EO 250 in the global market cap rankings as of March 19, 2026.
Key companies related to VETOQUINOL INH. EO 250 by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #422 globally with a market cap of $51.61 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #432 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #452 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #719 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #422 | Zoetis Inc | NYSE:ZTS | $51.61 Billion | $117.35 |
| #432 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.31 |
| #452 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #719 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
VETOQUINOL INH. EO 250 Historical Marketcap From 2021 to 2026
Between 2021 and today, VETOQUINOL INH. EO 250's market cap moved from $1.56 Billion to $ 947.14 Million, with a yearly change of -4.44%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €947.14 Million | -5.44% |
| 2025 | €1.00 Billion | +7.82% |
| 2024 | €928.97 Million | -24.03% |
| 2023 | €1.22 Billion | +19.04% |
| 2022 | €1.03 Billion | -33.98% |
| 2021 | €1.56 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of VETOQUINOL INH. EO 250 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $947.14 Million USD |
| MoneyControl | $947.14 Million USD |
| MarketWatch | $947.14 Million USD |
| marketcap.company | $947.14 Million USD |
| Reuters | $947.14 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.